Cite

HARVARD Citation

    Shaurova, T. et al. (2023). A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer. Cancer communications. 43 (4), pp. 503-507. [Online]. 
  
Back to record